Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 문진화 | - |
dc.date.accessioned | 2018-04-16T01:29:24Z | - |
dc.date.available | 2018-04-16T01:29:24Z | - |
dc.date.issued | 2012-10 | - |
dc.identifier.citation | Journal of Translational Medicine, 2012, 10(1) | en_US |
dc.identifier.issn | 1479-5876 | - |
dc.identifier.uri | https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-10-58 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11754/67283 | - |
dc.description.abstract | BackgroundsWe conducted a pilot study of the infusion of intravenous autologous cord blood (CB) in children with cerebral palsy (CP) to assess the safety and feasibility of the procedure as well as its potential efficacy in countering neurological impairment.MethodsPatients diagnosed with CP were enrolled in this study if their parents had elected to bank their CB at birth. Cryopreserved CB units were thawed and infused intravenously over 10~20 minutes. We assessed potential efficacy over 6 months by brain magnetic resonance imaging (MRI)-diffusion tensor imaging (DTI), brain perfusion single-photon emission computed tomography (SPECT), and various evaluation tools for motor and cognitive functions.ResultsTwenty patients received autologous CB infusion and were evaluated. The types of CP were as follows: 11 quadriplegics, 6 hemiplegics, and 3 diplegics. Infusion was generally well-tolerated, although 5 patients experienced temporary nausea, hemoglobinuria, or urticaria during intravenous infusion. Diverse neurological domains improved in 5 patients (25%) as assessed with developmental evaluation tools as well as by fractional anisotropy values in brain MRI-DTI. The neurologic improvement occurred significantly in patients with diplegia or hemiplegia rather than quadriplegia.ConclusionsAutologous CB infusion is safe and feasible, and has yielded potential benefits in children with CP. | en_US |
dc.description.sponsorship | This study was supported by a grant of the Korea Healthcare Technology R&D Project (A101712), Ministry for Health & Welfare, Republic of Korea. This work was supported by a grant from the Korea Science and Engineering Foundation (2010-0029508) through the MRC for Regulation of Stem Cell Behaviors at Hanyang University College of Medicine, Republic of Korea. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Biomed Central | en_US |
dc.subject | Cerebral palsy | en_US |
dc.subject | Cord blood | en_US |
dc.subject | Mononuclear cells | en_US |
dc.subject | Cell therapy | en_US |
dc.title | Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1186/1479-5876-10-58 | - |
dc.relation.journal | JOURNAL OF TRANSLATIONAL MEDICINE | - |
dc.contributor.googleauthor | Lee, Young-Ho | - |
dc.contributor.googleauthor | Choi, Kyung Vin | - |
dc.contributor.googleauthor | Moon, Jin Hwa | - |
dc.contributor.googleauthor | Jun, Hyun-Joo | - |
dc.contributor.googleauthor | Kang, Hye-Ryeong | - |
dc.contributor.googleauthor | Oh, Se-In | - |
dc.contributor.googleauthor | Kim, Hyung Sun | - |
dc.contributor.googleauthor | Um, Jang Soo | - |
dc.contributor.googleauthor | Kim, Mi Jung | - |
dc.relation.code | 2012213524 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | jinhwamoon | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.